Foamy-virus-mediated gene transfer to canine repopulating cells.
about
Foamy virus vectors for HIV gene therapyFoamy virus biology and its application for vector developmentHematopoietic-stem-cell-based gene therapy for HIV diseaseIntravenous injection of a foamy virus vector to correct canine SCID-X1.Centrosomal latency of incoming foamy viruses in resting cells.Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.Protection of stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection.The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.Foamy and lentiviral vectors transduce canine long-term repopulating cells at similar efficiency.Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.Large animal models of hematopoietic stem cell gene therapy.Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.Tracking of specific integrant clones in dogs treated with foamy virus vectors.Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo.High-titer foamy virus vector transduction and integration sites of human CD34(+) cell-derived SCID-repopulating cells.Advances in foamy virus vector technology and disease correction could speed the path to clinical applicationLarge animal models for foamy virus vector gene therapy.Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR.Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.Foamy virus vectors for gene transfer.Progress and prospects: foamy virus vectors enter a new age.Current progress on gene therapy for primary immunodeficiencies.Insulated Foamy Viral Vectors.Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia.In Vivo Hematopoietic Stem Cell Transduction.Foamy virus as a gene transfer vector to the central nervous system.In vivo selection of hematopoietic stem cells transduced at a low multiplicity-of-infection with a foamy viral MGMT(P140K) vector.Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.
P2860
Q26859020-CDE042E1-A8EF-496F-AEB8-FDA55DBD08C1Q26864134-310D8DB3-B956-474F-991F-3DF7B7E2CBD6Q27023434-5110290B-0FA2-493B-9BE8-43F970F6C2ADQ30409845-C62A5979-E124-4916-B800-1692CECE4861Q33285871-3F5447B6-28DA-491C-8198-A8C33B18DDA9Q33399020-19CB95ED-6B09-41B0-849D-C70BD46BE207Q33514823-EBB1E050-57D3-496C-8BBF-4D1A7276A3FFQ33676449-82E54081-204E-4E9F-BF53-A9034B3FBEA1Q33688423-2CBCE76C-EAA2-4196-BCA8-C4EEDB40A0F8Q33968014-D09C9980-F5CF-48F8-9C8C-8A3CF34851EEQ34039922-A2FDEF5D-F281-479E-84F4-60522C6D286EQ34428276-9F3677DE-368B-47A7-A518-E749DAED3E9BQ34589239-0D820BB8-6072-4406-8FAC-A064F1406EAAQ34819562-6C38C521-82EF-43A9-B65A-54BF1CEE796AQ35086128-B714E437-2CD2-4AF5-B01B-2BF96D44F7A1Q35182775-95E23F06-F9ED-450C-9E9D-CE1CF251711DQ35635430-8878CA30-3EA9-41B9-963F-7F9ED6B84AC3Q36014053-E04E7BFB-94F3-4804-9F17-B906D15BBD66Q36482767-C7388D41-6998-4F39-B1E6-A2A667C4D57DQ37001945-C2D5BCCE-A719-448E-93AC-752628B0E7FCQ37195758-CAA8AB18-88A8-4D0C-B7F6-394D5FBE6180Q37313583-4456F503-6D93-4CFA-B472-4DD5ADF726A6Q37594766-4873EDFB-BA3A-4FEC-BF1A-71FEC2307DA4Q37772765-DCF9CCC4-8C6E-4F79-9F1C-2E145420CE28Q38110363-AD25F8EA-F54B-4DBA-A2D1-5B3A7D30547FQ38808141-78228FAA-48DC-4E6A-8A7E-8B85FF96A77AQ39511486-9B284BDE-242B-4B50-A023-544A8141E320Q40045829-67B68D66-AB24-42A4-94F9-273F9AD9211EQ41121819-B17ECF5D-99BA-4D00-9BE2-878CDDAFF3F0Q41273368-31CA88AE-B410-4D75-9DFB-688E03773D1AQ45326104-9B0441C1-57EC-4007-A641-FD17A2E6F80EQ50878341-A1F9E4E6-4643-4C6F-8839-2C4A88250D4D
P2860
Foamy-virus-mediated gene transfer to canine repopulating cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Foamy-virus-mediated gene transfer to canine repopulating cells.
@ast
Foamy-virus-mediated gene transfer to canine repopulating cells.
@en
type
label
Foamy-virus-mediated gene transfer to canine repopulating cells.
@ast
Foamy-virus-mediated gene transfer to canine repopulating cells.
@en
prefLabel
Foamy-virus-mediated gene transfer to canine repopulating cells.
@ast
Foamy-virus-mediated gene transfer to canine repopulating cells.
@en
P2093
P2860
P1433
P1476
Foamy-virus-mediated gene transfer to canine repopulating cells.
@en
P2093
Erik Olson
Grant Trobridge
Hans-Peter Kiem
James Allen
Kirsten Keyser
Laura Peterson
P2860
P356
10.1182/BLOOD-2006-04-016741
P407
P577
2006-09-12T00:00:00Z